mTOR inhibition reverses Akt-dependent prostate intraepithelial neoplasia through regulation of apoptotic and HIF-1-dependent pathwaysPradip K. Majumder, William R. Sellers, Qi Xue et al.|Nature Medicine|2004Cited by 956
mTOR Inhibitor RAD001 (Everolimus) Has Antiangiogenic/Vascular Properties Distinct from a VEGFR Tyrosine Kinase InhibitorHeidi A. Lane, Terence O’Reilly|Clinical Cancer Research|2009Cited by 251
Effective <i>in vivo</i> targeting of the mammalian target of rapamycin pathway in malignant peripheral nerve sheath tumorsGunnar Johansson, Nancy Ratner, Yonatan Y. Mahller et al.|Molecular Cancer Therapeutics|2008Cited by 128